Total Payments
$4,628
2024 Payments
$1,375
Companies
28
Transactions
301
Medicare Patients
1,093
Medicare Billing
$97,450
Payment Breakdown by Category
Food & Beverage$4,628 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,628 | 301 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,031 | 71 | $0 (2024) |
| ABBVIE INC. | $564.64 | 47 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $555.83 | 27 | $0 (2024) |
| GlaxoSmithKline, LLC. | $349.81 | 24 | $0 (2024) |
| Merck Sharp & Dohme LLC | $331.55 | 24 | $0 (2023) |
| Lilly USA, LLC | $257.29 | 18 | $0 (2024) |
| PFIZER INC. | $223.46 | 16 | $0 (2024) |
| Amarin Pharma Inc. | $223.04 | 16 | $0 (2021) |
| Exact Sciences Corporation | $217.02 | 10 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $172.18 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,375 | 72 | AstraZeneca Pharmaceuticals LP ($309.39) |
| 2023 | $1,045 | 73 | Novo Nordisk Inc ($323.59) |
| 2022 | $342.82 | 24 | Novo Nordisk Inc ($130.00) |
| 2021 | $558.26 | 38 | GlaxoSmithKline, LLC. ($113.23) |
| 2020 | $525.35 | 37 | Amarin Pharma Inc. ($98.54) |
| 2019 | $470.58 | 35 | Merck Sharp & Dohme Corporation ($95.72) |
| 2018 | $203.44 | 15 | Novo Nordisk Inc ($68.14) |
| 2017 | $107.73 | 7 | Novo Nordisk Inc ($31.81) |
All Payment Transactions
301 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.88 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: PAIN | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $10.91 | General |
| 10/02/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Obesity | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Obesity | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.87 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Diabetes Care | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Obesity | ||||||
| 08/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 375 | 455 | $153,100 | $37,361 |
| 2022 | 4 | 121 | 137 | $48,430 | $10,647 |
| 2021 | 9 | 298 | 371 | $102,515 | $27,889 |
| 2020 | 11 | 299 | 368 | $87,270 | $21,553 |
Total Patients
1,093
Total Services
1,331
Medicare Billing
$97,450
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 149 | $64,640 | $13,798 | 21.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 96 | 96 | $42,555 | $13,341 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 109 | $33,650 | $6,754 | 20.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $5,365 | $1,099 | 20.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 15 | $1,650 | $1,076 | 65.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 21 | $2,190 | $690.27 | 31.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 33 | 38 | $515.00 | $319.20 | 62.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 13 | 13 | $2,535 | $283.43 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 60 | $26,050 | $5,483 | 21.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 24 | 24 | $10,590 | $3,489 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 38 | $11,640 | $1,630 | 14.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 15 | 15 | $150.00 | $44.82 | 29.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 136 | $50,320 | $13,106 | 26.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 49 | 49 | $19,355 | $7,198 | 37.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 51 | 60 | $15,300 | $2,809 | 18.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 26 | 26 | $9,490 | $1,915 | 20.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 17 | 20 | $4,400 | $1,416 | 32.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 13 | 13 | $1,430 | $839.82 | 58.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 18 | 18 | $720.00 | $337.50 | 46.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 17 | 17 | $1,020 | $172.90 | 17.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 27 | 32 | $480.00 | $96.00 | 20.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 47 | 98 | $36,260 | $8,354 | 23.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 40 | 40 | $15,800 | $5,134 | 32.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 61 | $15,555 | $2,870 | 18.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 25 | 25 | $2,750 | $1,512 | 55.0% |
About Dr. Opal Thakar, MD
Dr. Opal Thakar, MD is a Family Medicine healthcare provider based in Long Branch, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2013. The National Provider Identifier (NPI) number assigned to this provider is 1659792802.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Opal Thakar, MD has received a total of $4,628 in payments from pharmaceutical and medical device companies, with $1,375 received in 2024. These payments were reported across 301 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,628).
As a Medicare-enrolled provider, Thakar has provided services to 1,093 Medicare beneficiaries, totaling 1,331 services with total Medicare billing of $97,450. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Long Branch, NJ
- Active Since 12/13/2013
- Last Updated 04/12/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1659792802
Products in Payments
- VRAYLAR (Drug) $507.44
- Ozempic (Drug) $330.01
- Rybelsus (Drug) $260.36
- JANUVIA (Drug) $259.84
- Vascepa (Drug) $223.04
- Cologuard Collection Kit (Device) $217.02
- Wegovy (Drug) $205.35
- TRELEGY ELLIPTA (Drug) $198.60
- BREZTRI (Drug) $194.25
- NUEDEXTA (Drug) $172.18
- AIRSUPRA (Drug) $153.68
- FARXIGA (Drug) $107.49
- SYMBICORT (Drug) $100.41
- MOUNJARO (Drug) $94.02
- Kerendia (Drug) $88.42
- ANORO ELLIPTA (Drug) $86.02
- TRULICITY (Drug) $84.50
- QULIPTA (Drug) $60.09
- STEGLATRO (Drug) $58.06
- FREESTYLE LIBRE 3 (Device) $56.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.